INT-0116

Regimen

Experimental
surgery + adjuvant 5FU/leucovorin + 45 Gy chemoradiotherapy
Control
surgery alone

Population

Resected stomach or GEJ adenocarcinoma

Key finding

mOS 36 vs 27 mo (HR for death 1.35, 95% CI 1.09-1.66, P=0.005); mRFS 30 vs 19 mo (HR 1.52); 3y OS 50% vs 41%

Source: PMID 11547741

Timeline

    Guideline citations

    • NCCN GASTRIC (p.89)
    • CSCO GASTRIC 2025 (p.64)⚠️ OCR source